CereMark Pharma is leading the way on the science and technology to provide precise imaging of the brain pathology in cognitive impairment caused by Alzheimer’s Disease, and Chronic Traumatic Encephalopathy that often follows traumatic brain injury that occurs sports-related and accidental concussive events, combat-related or military training percussive events and bodily harm resulting from persistent domestic abuse. These traumatic events, research has shown, may lead to the development of pathological processes in the brain that cause cognitive decline in reasoning, behavior, memory and other executive brain functions. The resulting pathologies are signified by the presence of tau proteins and beta-amyloids in functional brain areas, so the detection and identification of tau and beta-amyloid in brain is critical to successful treatment.